Molecular Assessment of Nano-Hesperetin in Restoring Testosterone Biosynthesis and Antioxidant Balance in Testicular Toxicity

Husam Atiya Kadhim

doi:10.46795/ijhcbs.v7i3.937

Husam Atiya Kadhim Ministry of Education, General Directorate of Al-Qadisiyah Education, Diwaniyah 58001, Iraq

DOI https://doi.org/10.46795/ijhcbs.v7i3.937

Abstract

Chemotherapeutic drugs still represent a major clinical challenge for testicular toxicity mainly due to the persistent oxidative insult that disrupt steroidogenesis and spermatogenic function. Hesperetin, an aglycone citrus flavonoid, is widely known for its antioxidant action, but its medicinal utility is hampered by its poor water solubility and modest oral bioavailability. In the present study, hesperetin nanoparticles (Nano-Hesperetin) were synthesised by an antisolvent precipitation-ultrasonication method and characterised by FTIR, XRD and FESEM. Forty adult male Wistar rats were randomly allocated into four groups: Control, Cyclophosphamide (CP, 150 mg/kg), CP + free Hesperetin (50 mg/kg/day) and CP + Nano-Hesperetin (25 mg/kg/day). Serum testosterone, LH and FSH were tested by ELISA and testicular SOD, CAT, GSH and MDA were determined spectrophotometrically. The mRNA expression of StAR, CYP17A1 and Nrf2 was determined by quantitative RT-PCR. FESEM results showed the presence of almost spherical particles with an average particle size of around 81 nm. The crystalline nature of hesperetin was confirmed by the XRD. CP significantly reduced serum levels of testosterone and gonadotropins, depleted enzymatic antioxidants, increased MDA and downregulated the expression of steroidogenic and Nrf2 genes. When administered together, nano-hesperetin restored the hormonal balance, refilled the antioxidant pool and reactivated the StAR/CYP17A1 axis to near control levels, but free hesperetin only partially restored these parameters. The nano-formulation provided much better protection than the bulk flavonoid suggesting that reduction in particle size leads to improved testicular protection by jointly restoring steroidogenic gene expression and redox equilibrium.

Keywords: Nano-Hesperetin, Cyclophosphamide, Testicular toxicity, Testosterone, Oxidative stress, Steroidogenesis;, Nrf2

Downloads

Download data is not yet available.

References

1. Aitken RJ, Roman SD. Antioxidant systems and oxidative stress in the testes. Oxidative Medicine and Cellular Longevity. 2008;1(1):15–24.
2. Asadi N, Bahmani M, Kheradmand A, Rafieian-Kopaei M. The impact of oxidative stress on testicular function and the role of antioxidants in improving it: a review. Journal of Clinical and Diagnostic Research. 2017;11(5):IE01–IE05.
3. Tripathi DN, Jena GB. Effect of melatonin on the expression of Nrf2 and NF-κB during cyclophosphamide-induced urinary bladder injury in rat. Journal of Pineal Research. 2010;48(4):324–331.
4. Elangovan N, Chiou TJ, Tzeng WF, Chu ST. Cyclophosphamide-induced testicular damage and protective role of antioxidants. Toxicology. 2006;222(1–2):60–70.
5. Ghosh D, Das UB, Ghosh S, Mallick M, Debnath J. Testicular gametogenic and steroidogenic activities in cyclophosphamide-treated rat: a correlative approach to oxidative stress. Free Radical Research. 2002;36(11):1209–1218.
6. Parhiz H, Roohbakhsh A, Soltani F, Rezaee R, Iranshahi M. Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models. Phytotherapy Research. 2015;29(3):323–331.
7. Hwang SL, Yen GC. Neuroprotective effects of the citrus flavanones against H2O2-induced cytotoxicity in PC12 cells. Journal of Agricultural and Food Chemistry. 2008;56(3):859–864.
8. Kanaze FI, Bounartzi MI, Georgarakis M, Niopas I. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. European Journal of Clinical Nutrition. 2007;61(4):472–477.
9. Khan H, Ullah H, Tundis R, Belwal T, Devkota HP, Daglia M, et al. Dietary flavonoids in the management of male reproductive dysfunctions. Reproductive Toxicology. 2020;95:103–116.
10. Wang Y, Wang B, Lu J, Shi H, Gong S, Wang Y, et al. Hesperidin-nanoparticles improve oral bioavailability and biological activity: a comprehensive review. International Journal of Nanomedicine. 2021;16:1313–1330.
11. Sangsuwan R, Thummanetikul P, Eaknai W, Klaewsongkram J. Nanotechnology-based delivery of polyphenols: prospects for male reproductive protection. Journal of Functional Foods. 2022;88:104879.
12. Khan AW, Kotta S, Ansari SH, Sharma RK, Ali J. Self-nanoemulsifying drug delivery system (SNEDDS) of the poorly water-soluble grapefruit flavonoid naringenin: design, characterization, in vitro and in vivo evaluation. Drug Delivery. 2015;22(4):552–561.
13. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nature Methods. 2012;9(7):671–675.
14. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry. 1979;95(2):351–358.
15. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2^(−ΔΔCt) method. Methods. 2001;25(4):402–408.
16. Pandey AK. Synthesis, characterization and antibacterial activity of hesperetin nanoparticles. Journal of Drug Delivery Science and Technology. 2018;46:355–361.
17. Ahmad N, Ahmad I, Umar S, Iqbal Z, Samim M, Ahmad FJ. PNIPAM nanoparticles for targeted and enhanced nose-to-brain delivery of curcumin: out-performance over curcumin oral bioavailability. Drug Delivery. 2016;23(8):2095–2114.
18. Kalita B, Patwary BN. Formulation and in vitro evaluation of hesperidin–PVP solid dispersion: a flavonoid with limited bioavailability. Asian Journal of Pharmaceutical and Clinical Research. 2018;11(2):310–315.
19. Iqbal M, Bhandari KH, Najmi AK, Khar RK. Solid state characterization of hesperetin: a flavonoid with limited aqueous solubility. AAPS PharmSciTech. 2014;15(3):598–607.
20. Anwer MK, Iqbal M, Aldawsari MF, Alalaiwe A, Ahmed MM, Muharram MM. Improved antimicrobial activity and oral bioavailability of hesperetin nanoparticles prepared by nanoprecipitation. Pharmaceutics. 2020;12(5):412.
21. Khan J, Alexander A, Ajazuddin, Saraf S, Saraf S. Recent advances and future prospects of phyto-phospholipid complexation technique for improving pharmacokinetic profile of plant actives. Journal of Controlled Release. 2013;168(1):50–60.
22. Sahibzada MUK, Sadiq A, Faidah HS, Khurram M, Amin MU, Haseeb A, et al. Berberine nanoparticles with enhanced in vitro bioavailability: characterization and antimicrobial activity. Drug Design Development and Therapy. 2018;12:303–312.
23. Aditya NP, Macedo AS, Doktorovova S, Souto EB, Kim S, Chang PS, et al. Development and evaluation of lipid nanoparticles for quercetin delivery: a comparative study of solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), and lipid nanoemulsions (LNE). LWT - Food Science and Technology. 2014;59(1):115–121.
24. Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: damage and recovery. Journal of the National Cancer Institute Monographs. 2005;34:12–17.
25. Mohamadin AM, Sheikh B, El-Aal AA, Elberry AA, Al-Abbasi FA. Protective effects of nano-curcumin against cyclophosphamide-induced testicular injury in rats. Toxicology Reports. 2019;6:679–687.
26. El-Sheikh AA, Abdelzaher WY, Gad AA, Abdel-Gaber SA. Quercetin nanoparticles mitigate cisplatin-induced testicular damage through Nrf2/HO-1 activation. Biomedicine & Pharmacotherapy. 2021;143:112139.
27. Selvakumar E, Prahalathan C, Mythili Y, Varalakshmi P. Beneficial effects of DL-α-lipoic acid on cyclophosphamide-induced oxidative stress in mitochondrial fractions of rat testis. Chemico-Biological Interactions. 2005;152(1):59–66.
28. Stocco DM. StAR protein and the regulation of steroid hormone biosynthesis. Annual Review of Physiology. 2001;63:193–213.
29. Ma Q. Role of Nrf2 in oxidative stress and toxicity. Annual Review of Pharmacology and Toxicology. 2013;53:401–426.
30. Tonelli C, Chio IIC, Tuveson DA. Transcriptional regulation by Nrf2. Antioxidants & Redox Signaling. 2018;29(17):1727–1745.